share_log

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga ·  Mar 8 16:31

Gainers

  • Talphera (NASDAQ:TLPH) shares moved upwards by 15.6% to $1.3 during Friday's after-market session. The company's market cap stands at $22.0 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Genelux (NASDAQ:GNLX) shares increased by 10.06% to $7.0. The market value of their outstanding shares is at $187.0 million.
  • Estrella Immunopharma (NASDAQ:ESLA) stock rose 8.65% to $1.13. The market value of their outstanding shares is at $41.3 million.
  • Inspire Veterinary (NASDAQ:IVP) stock increased by 8.5% to $0.06. The market value of their outstanding shares is at $1.6 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) shares moved upwards by 5.15% to $0.65. The market value of their outstanding shares is at $59.1 million.
  • Fortrea Holdings (NASDAQ:FTRE) shares rose 5.02% to $38.68. The company's market cap stands at $3.4 billion.

Losers

  • Atara Biotherapeutics (NASDAQ:ATRA) shares decreased by 9.4% to $0.69 during Friday's after-market session. The market value of their outstanding shares is at $70.3 million.
  • ProKidney (NASDAQ:PROK) stock fell 7.51% to $1.54. The market value of their outstanding shares is at $104.5 million.
  • Mira Pharmaceuticals (NASDAQ:MIRA) stock declined by 7.01% to $1.46. The market value of their outstanding shares is at $21.5 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares fell 5.88% to $0.25. The company's market cap stands at $2.9 million.
  • GeneDx Hldgs (NASDAQ:WGS) shares fell 5.01% to $7.97. The company's market cap stands at $207.6 million.
  • Envoy Medical (NASDAQ:COCH) shares fell 5.0% to $8.55. The company's market cap stands at $167.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment